Five years after treat all implementation: Botswana's hiv response and future directions in the era of covid-19
Southern African Journal of HIV Medicine, ISSN: 2078-6751, Vol: 22, Issue: 1, Page: 1275
2021
- 6Citations
- 93Usage
- 66Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations6
- Citation Indexes4
- CrossRef1
- Policy Citations2
- Policy Citation2
- Usage93
- Full Text Views91
- 91
- Abstract Views2
- Captures66
- Readers66
- 66
Article Description
Background: As the relentless coronavirus disease-2019 (COVID-19) pandemic continues to spread across Africa, Botswana could face challenges maintaining the pathway towards control of its HIV epidemic. Objective: Utilising the Spectrum GOALS module (GOALS-2021), the 5-year outcomes from the implementation of the Treat All strategy were analysed and compared with the original 2016 Investment Case (2016-IC) projections. Future impact of adopting the new Joint United Nations Programme on HIV/AIDS (UNAIDS) Global AIDS Strategy (2021-2026) targets and macroeconomic analysis estimating how the financial constraints from the COVID-19 pandemic could impact the available resources for Botswana's National HIV Response through 2030 were also considered. Method: Programmatic costs, population demographics, prevention and treatment outputs were determined. Previous 2016-IC data were uploaded for comparison, and inputs for the GOALS, AIM, DemProj, Resource Needs and Family Planning modules were derived from published reports, strategic plans, programmatic data and expert opinion. The economic projections were recalibrated with consideration of the impact of the COVID-19 pandemic. Results: Decreases in HIV infections, incidence and mortality rates were achieved. Increases in laboratory costs were offset by estimated decreases in the population of people living with HIV (PLWH). Moving forward, young women and others at high risk must be targeted in HIV prevention efforts, as Botswana transitions from a generalised to a more concentrated epidemic. Conclusion: The Treat All strategy contributed positively to decreases in new HIV infections, mortality and costs. If significant improvements in differentiated service delivery, increases in human resources and HIV prevention can be realised, Botswana could become one of the first countries with a previously high-burdened generalised HIV epidemic to gain epidemic control, despite the demands of the COVID-19 pandemic.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85118300536&origin=inward; http://dx.doi.org/10.4102/sajhivmed.v22i1.1275; http://www.ncbi.nlm.nih.gov/pubmed/34853703; http://www.sajhivmed.org.za/index.php/HIVMED/article/view/1275; https://sajhivmed.org.za/index.php/hivmed/article/viewFile/1275/2619; https://sajhivmed.org.za/index.php/hivmed/article/viewFile/1275/2616; https://sajhivmed.org.za/index.php/hivmed/article/viewFile/1275/2617; https://sajhivmed.org.za/index.php/hivmed/article/viewFile/1275/2618; http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S2078-67512021000100046&lng=en&tlng=en; http://www.scielo.org.za/scielo.php?script=sci_abstract&pid=S2078-67512021000100046&lng=en&tlng=en; http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S2078-67512021000100046; http://www.scielo.org.za/scielo.php?script=sci_abstract&pid=S2078-67512021000100046; https://dx.doi.org/10.4102/sajhivmed.v22i1.1275; https://sajhivmed.org.za/index.php/HIVMED/article/view/1275
AOSIS
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know